Utility of antenatal HIV surveillance data to evaluate prevention of mother-to-child HIV transmission programs in resource-limited settings
Received 14 December 2006; received in revised form 20 March 2007; accepted 27 March 2007.
Prevention of mother-to-child human immunodeficiency virus (HIV) transmission (PMTCT) programs are expanding in resource-limited countries and are increasingly implemented in antenatal clinics (ANC) in which HIV sentinel surveillance is conducted. ANC sentinel surveillance data can be used to evaluate the first visit of a pregnant woman to PMTCT programs. We analyzed data from Kenya and Ethiopia, where information on PMTCT test acceptance was collected on the 2005 ANC sentinel surveillance forms. For Zimbabwe, we compared the 2005 ANC sentinel surveillance data to the PMTCT program data. ANC surveillance data allowed us to calculate the number of HIV-positive women not participating in the PMTCT program. The percentage of HIV-positive women missed by the PMTCT program was 17% in Kenya, 57% Ethiopia, and 59% Zimbabwe. The HIV prevalence among women participating in PMTCT differed from women who did not. ANC sentinel surveillance can be used to evaluate and improve the first encounter in PMTCT programs. Countries should collect PMTCT-related program data through ANC surveillance to strengthen the PMTCT program.
1Centers for Disease Control and Prevention/National Center for HIV, Hepatitis, STD, and TB Prevention/Global AIDS Program, Atlanta, GA
2Centers for Disease Control and Prevention/Global AIDS Program, Entebbe, Uganda
3Centers for Disease Control and Prevention/Global AIDS Program, Nairobi, Kenya
4National AIDS/STD Control Program, Nairobi, Kenya
5National HIV/AIDS Prevention and Control Office/Federal Ministry of Health, Addis Ababa, Ethiopia
6Centers for Disease Control and Prevention/Global AIDS Program, Addis Ababa, Ethiopia
7Elizabeth Glazer Pediatric AIDS Foundation, Harare, Zimbabwe
8Centers for Disease Control and Prevention/Global AIDS Program, Harare, Zimbabwe.
Reprints: Dr. Omotayo O. Bolu, MBBS, MSc, Centers for Disease Control and Prevention/National Center for HIV, Hepatitis, STD, and TB Prevention/Global AIDS Program/Prevention of Mother-to-Child Transmission Team, 1600 Clifton Rd, MS E-04, Atlanta, GA
The views expressed herein are those of the authors and do not necessarily represent the views of the U.S. Centers for Disease Control and Prevention.